Psychedelic ‘wonder drug' of the ‘60s can improve Parkinson's symptoms for weeks: study
Here's some groovy news.
A mind-bending blast from the past — once hailed as a 'wonder drug' that could cure everything from anxiety to addiction — is making a comeback.
3 A groundbreaking study has found that a popular drug can help relieve symptoms of Parkinson's disease.
Gamma-Rapho via Getty Images
Advertisement
Psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — is now showing serious promise for improving mood and motor function in people with Parkinson's disease, according to a groundbreaking recent study.
In the first trial of its kind, researchers administered a single dose of psilocybin to patients battling Parkinson's — a degenerative brain disorder that affects nearly 1 million Americans.
The results? Not just a safe trip, but one that delivered weeks of relief from the tremors, stiffness and depression that often plague patients.
Advertisement
'Many people don't realize this, but mood symptoms in Parkinson's are linked to a faster physical decline,' Ellen Bradley, an assistant professor of psychiatry and behavioral sciences at UC San Francisco, said in a statement.
'And they are actually a stronger predictor of patients' quality of life with Parkinson's than their motor symptoms.'
The study, published in the journal Neuropsychopharmacology, indicates participants handled the hallucinogen well — there were no serious side effects or worsening symptoms — and also experienced marked boosts in mood, memory and movement that stuck around long after they stopped taking the drug.
Advertisement
It's also a historic first: no psychedelic has been trialed in patients with a degenerative brain disease — until now.
3 Psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — is now showing serious promise for improving mood and motor function in people with the disease.
contentdealer – stock.adobe.com
'We are still in very early stages of this work, but this first study went well beyond what we expected,' Bradley said.
There is currently no cure for Parkinson's, though drugs like levodopa can help patients manage their symptoms. The good news is that treatment options are expanding.
Advertisement
Tavapadon — a new drug that mimics dopamine by targeting certain receptors — has shown promise in clinical trials by reducing motor fluctuations and maintaining symptom control with fewer side effects than traditional therapies.
Produodopa — a continuous infusion therapy first administered in the UK — was approved by the US Food and Drug Administration last fall.
3 'Many people don't realize this, but mood symptoms in Parkinson's are linked to a faster physical decline,' researcher Ellen Bradley said.
LIGHTFIELD STUDIOS – stock.adobe.com
Innovative approaches targeting the psychological aspects of the disease have been successful as well — with tandem cycling proving to be especially popular.
Some New Yorkers even find relief by playing pingpong.
'I just can't get enough of it,' NYU economics professor Bill Easterly previously told The Post. 'When I play pingpong, I just feel my brain come alive.'
Meanwhile, UCSF's Translational Psychedelic Research Program (TrPR) is planning larger trials to further investigate psilocybin's potential.
Advertisement
If future studies confirm these findings, magic mushrooms could become a powerful new tool in the fight against Parkinson's.
'The vast majority of brain diseases still lack interventions that change the course of illness,' said the study's senior author and TrPR director Joshua Woolley.
'We can often treat the symptoms, but we don't alter the trajectory or prevent decline. Now, that's beginning to change. These results raise the exciting possibility that psilocybin may help the brain repair itself.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
‘Unfathomable': Seth Rogen Torches Lawmakers Threatening Cuts to Medicaid
Lauren Miller Rogen was 22 years old, celebrating her graduation from college the first time she noticed something was happening to her mother, Adele. It was relatively minor: 'She repeated herself — she told a story a few times about a friend of hers,' Rogen says. But for Lauren, who had watched Adele care for her own parents as they slowly succumbed to Alzheimer's disease, it was the potential future that unnerved her. Within two years, Adele, a first-grade teacher, would be diagnosed with early-onset Alzheimer's at age 55. By that time, Lauren was living in Los Angeles, and dating her then-boyfriend, the actor Seth Rogen. When the couple married a few years later, Adele's condition had progressed to the point that it wasn't clear at their wedding if she even realized who Lauren was. 'She knew I was the bride — she kept calling me the bride,' Lauren recalled in Taking Care, a documentary the couple made to raise awareness about the challenges that families face while caring for a person with advancing dementia. The toll of caring for Adele was hardest on Lauren's father. 'There was a time early on, before we brought care in, where we were like, 'Oh, we're gonna lose him first.' This — caring for her — seemed like it's literally killing him,' she says. 'Without being able to afford outside help, I dread imagining what would have happened,' Lauren says. The couple went on to found a nonprofit, Hilarity for Charity, that disburses grants to offset the cost of caring for a person with dementia. 'Until we were part of the care system, we didn't realize how broken it was,' Seth says in a video they recorded on behalf of the organization Caring Across Generations, to raise alarms about the threat families face under a pair of proposals to slash health care programs for the poor and disabled that are being considered at the state and federal level, and encourage people to contact their legislators. He adds, 'Millions of low income families, families of people with disabilities, families that have older adults in them, are facing this struggle every day right now. And that is why it is so unfathomable that federal and state legislatures are making massive cuts to Medicaid as we speak.' 'We are cutting crucial services for people who are aging and disabled,' he explains. 'That means these people will be losing access or have less access to the health care they need, creating more out-of-pocket expenses and medical debt.' In Washington, President Donald Trump's 'Big Beautiful Bill,' which was recently approved by the Republican majority in the House of Representatives, would cut roughly $600 billion from Medicaid in order to help pay for a new round of tax cuts for the wealthy. The Trump tax bill is projected to kick over 10 million people off Medicaid, the government health insurance program for low-income and disabled Americans. The legislation would also limit so-called provider taxes, which states use to provide supplemental payments to hospitals, doctors, and other health care providers to help pay the costs of treating Medicaid patients. The bill would additionally impose a financial penalty on states, like California, that offer health coverage to undocumented immigrants. In California, the situation could be compounded by further cuts proposed by Governor Gavin Newsom (D) that would slash Medi-Cal, the state's Medicaid program. Roughly one quarter of the five million Americans with dementia rely on Medicaid, the country's largest payer of long-term care. Medicaid is a pillar for caregivers — some 12 percent of recipients are people who can't work because of their responsibilities caring for a family member. Their ability to access the program could be jeopardized by the Big Beautiful Bill, which would impose work requirements on all able-bodied adults under 65 in order to qualify for Medicaid. 'Almost everyone in this country knows or loves someone that relies on Medicaid, even if they don't rely on Medicaid themselves. And we have the power together,' Lauren says in the video. 'We need to reject any cuts or changes that would take more care away from families that need and deserve it,' Seth adds. 'At the state level and the federal level.' More from Rolling Stone Trump Continues Inflaming L.A. Protests: 'BRING IN THE TROOPS!!!' ABC News Suspends Journalist for Calling Stephen Miller and Trump 'World-Class Haters' Republicans Say They're Cool With Trump Deploying Troops Against Protesters Best of Rolling Stone The Useful Idiots New Guide to the Most Stoned Moments of the 2020 Presidential Campaign Anatomy of a Fake News Scandal The Radical Crusade of Mike Pence
Yahoo
28 minutes ago
- Yahoo
Big Data Can Make America Healthier. How to Do It Right
Credit - Ezra Bailey—Getty Images Big data can help make Americans healthier, and the Trump Administration has stated—in its recently released Make America Healthy Again report and elsewhere—that building a national big-data platform is one of its primary goals. As scientists who use large data sets to study health, we're excited about its potential and the willingness of the federal government to invest in it, particularly since big data has been underutilized in the U.S. compared with other developed countries—and since the number of ways it can be used grows nearly daily. It's a huge opportunity. But there are lots of concerns when assembling sensitive health data and combining it with other sensitive data, like credit scores, tax records, employment, educational records, and more. Some of those concerns with the Administration's plans have already surfaced. The Administration's first goal of assembling big data to studying autism has left some worried that if used inappropriately, such data could lead to harm, rather than help, for those with autism. Others worry that big data could be used to perform and justify shoddy research that supports predetermined conclusions without adhering to rigorous scientific methods—a concern reinforced by the discovery that the Make America Healthy Again report cited non-existent sources to support its claims. So how can we reap the benefits of big data while minimizing its risks? Here are some guiding principles: The health care system already possesses health data on millions of Americans. Medical records are now almost always digitized, permitting doctors' notes, medical imaging, laboratory tests, insurance claims, and more to be linked (in theory) across doctors' offices, hospitals, nursing homes, and any other place people receive care. However, data collected about a patient in one setting often doesn't get connected to data from other settings—making it hard for researchers to get a full picture of what, exactly, is happening to each of us within the larger health care system. Read More: Gun Injuries of All Kinds Go Up During Hunting Season The federal government also has data on us that can be connected to health care data to answer important questions. For example, comprehensive and detailed data on Americans' occupations linked with health, insurance, and other data could help shed more light on relationships between our work and our health—helping to better answer curious questions like why taxi drivers are less likely to die from Alzheimer's disease or why female physicians don't outlive their male colleagues. The first step of making big data more helpful is to simply link the data—which, while possible, is difficult to accomplish without centralized effort. Once linkages have been made, data can be anonymized so that those studying sensitive questions aren't privy to confidential information about specific individuals. In addition to governmental data, many other sources of data can provide insights into our health. For example, smartwatches not only have data on how our hearts are beating (e.g., they can identify abnormal heart rhythms like atrial fibrillation), but they can also identify subtle changes in mobility that might be predictive of early neuromuscular diseases like Parkinson's disease. Meanwhile, grocery stores have data on the foods we eat, and with increasing interest in how diet affects our lives, these data could be linked to detailed measures of health. Read More: Could the Shingles Vaccine Help Prevent Dementia? Similarly, social-media platforms possess data that can offer insights into changes in our mental health, and through large-scale analysis of online photos could even identify, in real time, early visible markers of disease. These are moonshots, of course, and whether we want to use data in this way is an open question. But the potential to improve health could be large. Creating a way for scientists to link outside data to existing government and health data—while responsibly maintaining individual anonymity after the linkage—could open many novel research opportunities. Keeping all of these data sources organized, secure, and accessible to scientists is a tall order. Researchers who use big data often dedicate substantial resources to finding the data they need, organizing it, and ensuring its accuracy; the better the database is maintained, the easier it is for researchers to actually perform their analyses. The secure online platform where Medicare and other government health care data are currently accessed has been described by researchers as 'tedious and prone to system errors' and in need of major improvements. Meanwhile, security concerns have led the government to stop letting researchers store the data on their own secure servers, the easiest and most cost-effective way to actually work with the data. Access to Medicare data by researchers has become prohibitively expensive, costing about $30,000 a year or more for a single user to work on one project using the online platform. Read More: Why We Can't Rely on Science Alone to Make Public Health Decisions Proposals to drastically cut medical research funding have been reported, and if passed, these research funding cuts will come at the cost of discoveries to improve health that will never be made. High-quality research of any kind requires investment, whether it's in a biology lab under a microscope or working with data on powerful computers. A new data platform is only as valuable as researchers' ability to access it in a functional and cost-effective way. Any roadmap to designing a national data platform that links together health care and other sensitive data must consider the many valid concerns about collecting data in the U.S., including privacy concerns and how data will be used. The Pew Research Center finds that large majorities of Americans say they are concerned about how the government uses data collected about them (71%), while also admitting that they have little to no understanding of what the government even does with such data (77%). Here are some strategies—in addition to many of the cybersecurity and privacy safeguards already in place—to both protect the data and help earn the public trust: Mistrust and unease with government data collection is readily traceable to historical abuse of Americans' data (as well as recent allegations of improper access), so it's not surprising that many are wary of the Trump Administration's plans. Ensuring data cannot be weaponized by the government against individuals is perhaps the single biggest barrier to creating a useful database, but it can be done. Those currently using federal health care data must already undergo training and comply with very high data-security standards. Misuse of the data—such as even attempting to figure out the identity of an anonymous individual in the data—or failure to protect patient privacy can lead to criminal penalties. A platform of sensitive data without well-delineated restrictions on who can use it and what they can use it for is a recipe for problems. Other ongoing efforts by the Administration to compile data under the vague goal of 'increasing government efficiency' have been met with pushback and lawsuits from organizations concerned about data being used against members of the public. Current use of federal health data also requires researchers to provide the government detailed plans to justify the use of specific data. This allows the government to ensure that no more data than is needed to answer the specific question is provided to researchers. Read More: Why Do Taxi Drivers Have a Lower Risk of Alzheimer's? Researchers must also obtain ethical approval from an Institutional Review Board prior to accessing and analyzing data, a second checkpoint. These boards, which exist in light of egregious failures of medical research ethics in the 20th century, help ensure that analyses are designed to minimize risk to patients—even if it is only their data, and not their bodies, at risk. Transparency into who is using this sensitive data and what exactly they are doing with it can engender trust between researchers and the American public. Just like researchers already do for clinical trials, those accessing the data platform should specify their plans in advance, and those plans should be easily and publicly available. Transparency around which data were accessed and what computer code was used to analyze it not only promotes trust, but such data- and code-sharing practices among researchers make it easier to appraise the quality of the work, identify mistakes, and root out misconduct. We can only assume that Americans' unease with governmental data use stems from knowledge that, as with all powerful tools, linked data has the potential to be used in potentially harmful ways. But when in the hands of qualified scientists using rigorous scientific methods and privacy safeguards, a robust real-world data platform like this could lead to new discoveries about how all of us can lead healthier lives. Contact us at letters@
Yahoo
38 minutes ago
- Yahoo
Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®
New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep disruption DALLAS, June 9, 2025 /PRNewswire/ -- Health-E Commerce, the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated to selling only FSA- and HSA-eligible products and services, announced today that it has expanded its telehealth collaboration with LifeMD™, a leader in virtual care. This latest initiative gives FSA and HSA users affordable, convenient access to FDA-approved prescription sleep treatments at a time when better sleep care is urgently needed. According to the CDC, insufficient sleep is linked to higher risks of obesity, diabetes, heart disease, and depression, which means expanded access to treatment is not just beneficial, it's essential. The arrangement allows new customers who shop at FSA Store or HSA Store to receive 50% off prescription sleep medications from LifeMD, with no in-person appointments required. Following a free virtual consultation, approved patients can have non-addictive, physician-prescribed treatments discreetly delivered to their door, making it easier than ever to address sleep concerns with clinically backed solutions. "The connection between sleep and our overall physical and mental health is undeniable, and poor sleep can even impact our productivity at work and our overall quality of life," said Keri Kaiser, chief revenue officer for Health-E Commerce. "The expansion of our telehealth collaboration with LifeMD gives consumers more options for diagnosing and treating sleep disorders and improving sleep health, while saving money by using tax-free FSA- and HSA-eligible services. We're proud to simplify access to care for millions of Americans and to maximize their healthcare dollars." Many individuals who experience poor sleep rely on over-the-counter remedies that may not be effective for persistent insomnia or sleep disruptions. Fortunately, LifeMD's prescription sleep solutions are designed to address the root causes of poor sleep with medications that target sleep onset, duration, and quality, including Ramelteon, Doxepin, and Trazodone. Eligibility for prescription treatments is determined by a licensed LifeMD physician and backed by LifeMD's 4.9-star patient satisfaction rating. "We're proud to expand our telehealth collaboration with Health-E Commerce to give individuals and families who are enrolled in FSAs and HSAs access to clinical support to improve sleep health and their overall quality of life," said Nicholas Alvarez, co-founder and chief acquisition & growth officer at LifeMD. "Everyone deserves access to quality medical care that is convenient and affordable, and by collaborating with FSA Store and HSA Store, we are able to effectively extend the reach of our services to individuals and families across the country." LifeMD's sleep solutions are now available at and alongside other telehealth services for home sleep apnea testing, CPAP devices and supplies, CPAP alternatives, and more. This launch reinforces Health-E Commerce's mission to make tax-free healthcare dollars work harder for the more than 70 million Americans enrolled in pre-tax health accounts. To learn more or access eligible sleep health services and products, visit or About Health-E CommerceHealth-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill®, a popular private-label line of health products through which a portion of every purchase is donated to the Children's Health Fund. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding eligibility for important new product and telehealth categories within the list of eligible medical expenses. About LifeMDLifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit View original content to download multimedia: SOURCE Health-E Commerce Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
